Benzinga | Nov 9, 2021 05:14PM EST

Inovio Pharmaceuticals Q3 EPS $(0.29) Beats $(0.33) Estimate, Sales $292.00K Miss $970.00K Estimate

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.33) by 12.12 percent. This is a 11.54 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $292.00 thousand which missed the analyst consensus estimate of $970.00 thousand by 69.90 percent. This is a 99.88 percent decrease over sales of $236.18 million the same period last year.